• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    Tafasitamab
    |
    Weekly News Recap #Phispers Tafasitamab
    FDA approves Wockhardt’s antibiotic for complicated UTIs; Pfizer inks up to US$ 10.5 billion deal with Innovent

    FDA approves Wockhardt’s antibiotic for complicated UTIs; Pfizer inks up to US$ 10.5 billion deal with Innovent

    This week’s Phispers is full of news about deals and clinical trials emerging out of the recently concluded annual meetin...

    Impressions : 958

    Sanofi, Earendil Labs ink up to US$ 2.56 bn AI-driven autoimmune drug deal; CDC revises childhood immunization guidelines

    Sanofi, Earendil Labs ink up to US$ 2.56 bn AI-driven autoimmune drug deal; CDC revises childhood immunization guidelines

    The New Year began with two mid-size deals centered around the use of artificial intelligence (AI) in drug development. Sanofi...

    Impressions : 1514

    IRA price talks conclude, three meds dominate savings; Gilead’s Livdelzi from CymaBay buyout gets FDA okay

    IRA price talks conclude, three meds dominate savings; Gilead’s Livdelzi from CymaBay buyout gets FDA okay

    This week, the Biden-Harris Administration said it has concluded price negotiations for 10 drugs under the Inflation Reduction ...

    Impressions : 1123

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.